UB Paderborn / Katalog / Suche / in CDI

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY

HemaSphere, 2023-08, Vol.7 (S3), p.e2687131

2023

Link zum Volltext

Verfügbarkeit prüfen

Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications

Clinical & developmental immunology, 2012-01, Vol.2012, p.756353-24

2012

Link zum Volltext

Verfügbarkeit prüfen

Knowledge graphs for enhancing transparency in health data ecosystems

Semantic Web, 2023-01, Vol.14 (5), p.943

2023

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer

Scientific reports, 2020-12, Vol.10 (1), p.21147-21147, Article 21147

2020

Link zum Volltext

Verfügbarkeit prüfen

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab

Case reports in oncology, 2012-12, Vol.5 (3), p.676-681

2012

Link zum Volltext

Verfügbarkeit prüfen

Old and New Insights in the Treatment of Thyroid Carcinoma

Journal of Thyroid Research, 2010-01, Vol.2010, p.279468-16

2010

Link zum Volltext

Verfügbarkeit prüfen

Melanoma: from darkness to promise

American journal of clinical oncology, 2011-04, Vol.34 (2), p.179-187

2011

Link zum Volltext

Verfügbarkeit prüfen

High-dose Chemotherapy Followed by Autologous and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Follicular Non-Hodgkin's Lymphoma in the Rituximab Era

Tumori, 2015-01, Vol.101 (1), p.2-7

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma

Molecular and clinical oncology, 2016-01, Vol.4 (1), p.93-99

2016

Link zum Volltext

Verfügbarkeit prüfen

Cribado de cáncer de pulmón con tomografía computarizada de baja dosis. Reflexiones sobre su aplicación en España

Medicina clínica, 2016-10, Vol.147 (8), p.366-370

2016

Link zum Volltext

Verfügbarkeit prüfen

Cribado de cáncer de pulmón con tomografía computarizada de baja dosis. No es cuestión de logística

Archivos de bronconeumología, 2017-10, Vol.53 (10), p.593-594

2017

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant therapy in lung cancer stage IIIA: the new role of chemo-immunotherapy

Anales de la Real Academia Nacional de Medicina, Madrid, 2019-05, Vol.136 (1), p.17-24

Provencio-Pulla, Mariano

2019

Link zum Volltext

Verfügbarkeit prüfen

Tratamiento neoadyuvante del cáncer de pulmón estadio IIIA: el nuevo papel de la quimio-inmunoterapia

Anales de la Real Academia Nacional de Medicina, Madrid, 2019-01, Vol.136 (1), p.17

Mariano Provencio Pulla

2019

Link zum Volltext

Verfügbarkeit prüfen

Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab

Clinical & translational oncology, 2010-10, Vol.12 (10), p.701-703

2010

Link zum Volltext

Verfügbarkeit prüfen

Contra: el cribado del cáncer de pulmón con tomografía computarizada de baja dosis

Gaceta sanitaria, 2016-09, Vol.30 (5), p.383-385

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells in breast cancer: methodology and clinical repercussions

Clinical & translational oncology, 2008-07, Vol.10 (7), p.399-406

2008

Link zum Volltext

Verfügbarkeit prüfen

Low-dose CT for lung cancer screening

The lancet oncology, 2018-03, Vol.19 (3), p.e131-e132

2018

Link zum Volltext

Verfügbarkeit prüfen

Measuring the great objective: Have we transferred the increase in overall survival in stage IV non-small cell lung cancer from clinical trials to clinical practice?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18734-e18734

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying prognostic and predictive value of mutations associated with clinical outcomes in first line (1L) patients with advanced or metastatic non–small cell lung cancer (aNSCLC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9047-9047

2022

Link zum Volltext

Verfügbarkeit prüfen

Promotion of anti-smoking strategies as the most effective and efficient way to reduce lung cancer (and other diseases)

Archivos de bronconeumología (English ed.), 2020-05, Vol.56 (5), p.339

2020

Link zum Volltext

Verfügbarkeit prüfen

Sexual dysfunction in patients with cancer: Results from the CLARIFY project

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.12094-12094

2023

Link zum Volltext

Verfügbarkeit prüfen

Survival outcomes in ALK-positive NSCLC patients (p) treated 1 st line brigatinib and impact of the ALK fusion variant

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21015-e21015

2023

Link zum Volltext

Verfügbarkeit prüfen

Fomento de las estrategias antitabaco como la manera más efectiva y eficiente de reducir el cáncer de pulmón (y otras enfermedades)

Archivos de bronconeumología, 2020-05, Vol.56 (5), p.339-339

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY

Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications

Knowledge graphs for enhancing transparency in health data ecosystems

Polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab

Old and New Insights in the Treatment of Thyroid Carcinoma

Melanoma: from darkness to promise

High-dose Chemotherapy Followed by Autologous and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Follicular Non-Hodgkin's Lymphoma in the Rituximab Era

Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma

Cribado de cáncer de pulmón con tomografía computarizada de baja dosis. Reflexiones sobre su aplicación en España

Cribado de cáncer de pulmón con tomografía computarizada de baja dosis. No es cuestión de logística

Neoadjuvant therapy in lung cancer stage IIIA: the new role of chemo-immunotherapy

Tratamiento neoadyuvante del cáncer de pulmón estadio IIIA: el nuevo papel de la quimio-inmunoterapia

Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab

Contra: el cribado del cáncer de pulmón con tomografía computarizada de baja dosis

Circulating tumor cells in breast cancer: methodology and clinical repercussions

Low-dose CT for lung cancer screening

Measuring the great objective: Have we transferred the increase in overall survival in stage IV non-small cell lung cancer from clinical trials to clinical practice?

Identifying prognostic and predictive value of mutations associated with clinical outcomes in first line (1L) patients with advanced or metastatic non–small cell lung cancer (aNSCLC)

Promotion of anti-smoking strategies as the most effective and efficient way to reduce lung cancer (and other diseases)

Sexual dysfunction in patients with cancer: Results from the CLARIFY project

Survival outcomes in ALK-positive NSCLC patients (p) treated 1 st line brigatinib and impact of the ALK fusion variant

Fomento de las estrategias antitabaco como la manera más efectiva y eficiente de reducir el cáncer de pulmón (y otras enfermedades)

Suchergebnisse filtern